At each vaccination site, an on-site medical team is provided by GeneIQ Vaccine Direct, along with a registration platform, to ensure effective treatment and all state reporting requirements are met. Patients can receive the vaccine for free with insurance or through the federal government’s program for uninsured persons.
The announcement comes as GeneIQ expands its ongoing partnerships with local schools, businesses and community organizations to provide various COVID-19 services to public and private institutions, including a recent partnership with Texas Women’s University (TWU) to provide mandatory weekly COVID-19 tests to unvaccinated students, faculty and staff enrolled at the three campuses of the Dallas-Fort Worth metroplex. GeneIQ also has ongoing partnerships with Tarrant County and Dallas colleges providing COVID-19 testing at the majority of each school’s area campuses.
GeneIQ has organized over 130 vaccination clinics in the past 90 days and administered thousands of vaccines locally since the start of the year.
To learn more about GeneIQ and its diagnostic offerings, visit GeneIQ website. To learn more about testing options for your business or campus, please call 972-942-0110 or email [email protected].
GeneIQ is a high-volume molecular diagnostic laboratory specializing in pharmacogenomic testing (PGx) and real-time reverse transcriptase polymerase chain reaction (RT-PCR) testing for urinary tract and respiratory infections, including COVID-19. The state-of-the-art laboratory based in Dallas local services to over 500 long-term care facilities, physician offices, state and local governments, businesses and organizations across United States. They created a highly efficient automated lab process with a web-based paperless system that provides 24 hour turnaround time for results after sample receipt. At the heart of GeneIQ are the latest innovations in pharmacogenomics, the science that determines how genetic variability influences physiological responses to drugs, from absorption and metabolism to pharmacological action and therapeutic effect. With the goal of providing precision medicine and meeting the needs of the pandemic with molecular precision, GeneIQ’s support and management teams are passionate about providing the highest level of service to their customers and to the community. entire health sector.
About GeneIQ Vaccine Direct
GeneIQ Vaccine Direct is committed to supporting schools, businesses and organizations with COVID-19 vaccinations onsite and at no cost. GeneIQ Vaccine Direct is approved by the DSHS to deliver Moderna, Pfizer and Johnson & Johnson vaccines and boosters.
GeneIQ has been a trusted resource throughout the pandemic and has served over a quarter of a million patients across the country, playing a central role throughout the pandemic. GeneIQ Vaccine Direct provides vaccines and reminders on-site in a safe and convenient process at no cost to the patient or the organization. Supplies, medical staff, and the enrollment platform are all included in the end-to-end service.